AAAAAA

   
Results: 1-4 |
Results: 4

Authors: HACKAM DJ CHRISTOU N KHALIQ Y DUFFY DR VAUGHAN D MARSHALL JC ROTSTEIN OD
Citation: Dj. Hackam et al., BIOAVAILABILITY OF ORAL CIPROFLOXACIN IN EARLY POSTSURGICAL PATIENTS, Archives of surgery, 133(11), 1998, pp. 1221-1225

Authors: OPAL SM FISHER CJ DHAINAUT JFA VINCENT JL BRASE R LOWRY SF SADOFF JC SLOTMAN GJ LEVY H BALK RA SHELLY MP PRIBBLE JP LABRECQUE JF LOOKABAUGH J DONOVAN H DUBIN H BAUGHMAN R NORMAN J DEMARIA E MATZEL K ABRAHAM E SENEFF M BARBER A BRAYMAN K CERRA F CHALFIN D CHAZEN G CHRISTOU N COONEY R CORBIN R DREW R EMMANUEL G PINES B ERON L FLETCHER R FOULKE G GALLAGHER T GERVICH D GROSSMAN J HALPERN N HANNA C JOHNSON S KUBAK B LODATO R LOVETT M MARSHALL J METZLER M NELSON L FREELAND M OROPELLO J PAZ H RACKOW E RIKER R RISSING P SCHEIN R SCHELD M SCHUSTER D SIBBALD W SILVERMAN H SOMERMEYER M STRANGE C SUMMER W TOPIEL M WHITE J ALESTIG K ANDERSEN PK ANDERSSON J BENNETT D BERG S BLEICHNER G BRUNET F CARLET J DEJONG MJ DREXLER H GARRARD C HESLET L KLOSS T PAUL W REINHART K RENAUD B RITZ R ROMME JH SCHMITZ JE STOCKENHUBER F SUTER P TENAILLON A VAGT A VANDERMEER WM VANDEVENTER S VANLEEUWEN PAM VERHOEF J WEBSTER N WINTER RJ WOLFF M STILES DM DEVOS A CROFT C FAZIO J THOMPSON R WIEDEMANN H ELLISON RT CHINCHILLI VM YARBOROUGH M
Citation: Sm. Opal et al., CONFIRMATORY INTERLEUKIN-1 RECEPTOR ANTAGONIST TRIAL IN SEVERE SEPSIS- A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL, Critical care medicine, 25(7), 1997, pp. 1115-1124

Authors: AHMED N CHRISTOU N
Citation: N. Ahmed et N. Christou, SYSTEMIC INFLAMMATORY RESPONSE SYNDROME - INTERACTIONS BETWEEN IMMUNECELLS AND THE ENDOTHELIUM, Shock, 6, 1996, pp. 39-42

Authors: TAN JS WISHNOW RM TALAN DA DUNCANSON FP NORDEN CW HANNA C CHRISTOU N BERNSTEIN J MARSH P SMITH M SAPICO F MURRAY G CROCKERSMITH LL SEGRETI J GENTRY L CULLISON J SATHE S LOW I LAMOTHE F MERSEY J DALL L LAVERDIERE M MITCHELL J
Citation: Js. Tan et al., TREATMENT OF HOSPITALIZED-PATIENTS WITH COMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS - DOUBLE-BLIND, RANDOMIZED, MULTICENTER STUDY OF PIPERACILLIN-TAZOBACTAM VERSUS TICARCILLIN-CLAVULANATE, Antimicrobial agents and chemotherapy, 37(8), 1993, pp. 1580-1586
Risultati: 1-4 |